Checking more than teeth

Checking more than teeth April 15, 2017 Vigilant Biosciences was featured in a snapshot in USA Today on April 15th for Oral Cancer Awareness Month. The snapshot highlights the number of people expected to be diagnosed with oral or oropharyngeal cancer this year in the U.S. to help raise awareness for the importance of screening for the

New detection method could help identify oral cancer sooner

New detection method could help identify oral cancer sooner April 10, 2017 Vigilant Biosciences’ Scientific Co-Founder and Chief Scientific Officer Elizabeth Franzmann, M.D., recently caught up with WPLG to discuss oral cancer and the Company’s OncAlert Oral Cancer product line. Back to News

Oral Cancer Awareness Month Hopes to Educate Public on Risks

Oral Cancer Awareness Month Hopes to Educate Public on Risks April 4, 2017 According to a recent survey released today from Vigilant Biosciences, in collaboration with the Oral Cancer Foundation, HNCA and SPOHNC, more than 60% of consumers know very little or nothing about oral cancer – a disease that nearly 50,000 people are diagnosed

Oral Cancer Awareness Survey Reveals Majority of U.S. Adults Want to Be Screened for Oral Cancer

Oral Cancer Awareness Survey Reveals Majority of U.S. Adults Want to Be Screened for Oral Cancer April 4, 2017 According to a recently released national survey, the majority (62 percent) of adults in the U.S. know very little, or nothing at all, about oral cancer (including cancer of the oral cavity, tongue, larynx and pharynx),

Survey: Only 29% of patients screened for oral cancer

Survey: Only 29% of patients screened for oral cancer March 31, 2017 Only 29% of U.S. patients reported being screened for oral cancer at their last visit to the dental office, according to a new survey released by the Oral Cancer Foundation, the Head and Neck Cancer Alliance, Vigilant Biosciences, and Support for People with Oral

Vigilant spearheads oral cancer survey to gauge patient awareness

Vigilant spearheads oral cancer survey to gauge patient awareness March 30, 2017 According to a recent survey conducted by Vigilant Biosciences in collaboration with the Oral Cancer Foundation, Head and Neck Cancer Alliance, and Support for People with Oral and Head and Neck Cancer, more than 60% of consumers know very little or nothing about oral cancer—a disease that nearly 50,000 people are

Oral Cancer Awareness Survey Reveals 81 Percent of U.S. Adults Want to Be Screened for Oral Cancer During Routine Dental Check-ups

Oral Cancer Awareness Survey Reveals 81 Percent of U.S. Adults Want to Be Screened for Oral Cancer During Routine Dental Check-ups March 30, 2017 According to a national survey released today, the majority (62 percent) of adults in the U.S. know very little, or nothing at all, about oral (including cancer of the oral cavity, tongue, larynx

Oral Cancer Tests Capture Biomarkers Using Saline Rinse

Oral Cancer Tests Capture Biomarkers Using Saline Rinse March 27, 2017 The OncAlert oral cancer product line from Vigilant Biosciences Inc, Fort Lauderdale, Fla, is now available in select markets. The company’s OncAlert oral cancer product line includes the OncAlert oral cancer rapid test and the OncAlert oral cancer lab test, available in countries accepting the

Ever Vigilant: A Fort Lauderdale Company Is Becoming an International Leader in Oral Cancer Prevention

Ever Vigilant: A Fort Lauderdale Company Is Becoming an International Leader in Oral Cancer Prevention January 30, 2017 For Matthew Kim, the idea for his company came when he was taking his mother to doctor visits for her cancer treatments. She was on her third battle with oral cancer, while Kim had a consulting firm

Startup Sector Expects to Flex More Muscle in 2017

Startup Sector Expects to Flex More Muscle in 2017 January 6, 2017 When Matthew Kim, founder and CEO of Vigilant Biosciences in Fort Lauderdale started his company in 2011, he quickly found funding to be a serious challenge. Ultimately, he persuaded an out-of-state investor to help, but in his most recent financing round, he received

© 2020 Vigilant Biosciences

Follow Us

3900001 Rev2